Jacob Mekhael

Judah Frommer

Sebastiaan van der Schoot

Philip Nadeau

Sean McCutcheon

Alex [on for Phil Nadeau]

Brian Abrahams

Chi Fong

Dane Leone

David Seynnaeve

Faisal Khurshid

Manos Mastorakis

Shan Hama

Xian Deng

- Galapagos' Board of Directors decided on **May 13, 2025**, to explore strategic alternatives for its Cell Therapy Business, including a potential divestiture.  **[1421876_0001171843-25-006227_exh_991.htm:0]** 
- As of **October 1, 2025**, the Board has received a **limited number of non-binding offers** from consortia, predominantly comprised of financial investors, to acquire the Cell Therapy Business.  **[1421876_0001171843-25-006227_exh_991.htm:0]** 
- The deadline for potential bidders to submit **binding, fully-financed offers** is in the coming weeks.  **[1421876_0001171843-25-006227_exh_991.htm:0]** 
- Galapagos expects to announce the outcome of the strategic review no later than **November 5, 2025**, with the release of its third-quarter financial results.  **[1421876_0001171843-25-006227_exh_991.htm:0]**

Galapagos Provides Update on Strategic Alternatives for Cell Therapy Business

GALAPAGOS (GLPG)